Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH

Title:Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH

Volume: 27 Issue: 21

Author(s): Panagiotis Anagnostis, Christos V. Rizos, Ioannis Skoumas, Loukianos Rallidis, Konstantinos Tziomalos, Emmanuel Skalidis, Vasileios Kotsis, Michalis Doumas, Genovefa Kolovou, George Sfikas, Eleni Bilianou, Iosif Koutagiar, Dimitrios Agapakis, Evangelos Zacharis, Christina Antza, Charalambos Koumaras, Chrysoula Boutari, George Liamis and Evangelos N. Liberopoulos*

Affiliation:

• Department of Internal Medicine, Medical School, University of Ioannina, Ioannina,Greece

Keywords: Familial hypercholesterolemia, HELLAS-FH, carotid artery disease, chronic kidney disease, non-alcoholic fatty liver disease, hepatic steatosis, peripheral arterial disease, lower extremity arterial disease, aortic stenosis.

Abstract:

Aims: Despite the established link between familial hypercholesterolemia (FH) and increased risk of coronary heart disease (CHD), its association with other common atherosclerotic and metabolic diseases has not been extensively studied. The aim of this study was to report the prevalence of peripheral arterial disease (PAD) [i.e., common carotid artery disease (CCAD) and lower extremity arterial disease (LEAD)], aortic valve stenosis, chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) in patients with FH.

Materials & Methods: This was a cross-sectional study retrieving data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

Results: A total of 1,633 adult patients (850 males) with heterozygous FH (HeFH) were included (mean age 51.3±14.6 years at registration and 44.3±15.9 years at diagnosis). Any common carotid artery stenosis (CCAS) was diagnosed in 124 out of 569 patients with available related data (21.8%), while the prevalence of CCAD (defined as a CCAS ≥50%) was 4.2%. The median (interquartile range - IQR) CCAS was 30% (20-40), whereas the median (IQR) carotid intima-media thickness (CIMT) was 0.7 (0.1-1.4) mm. LEAD was reported in 44 patients (prevalence 2.7%). The prevalence of aortic valve stenosis and CKD was 2.0% and 6.4%, respectively. NAFLD was present in 24% of study participants.

Conclusion: HeFH is associated with a relatively high prevalence of any CCAS and CCAD. The prevalence of LEAD, CKD and aortic valve stenosis was relatively low, whereas the prevalence of NAFLD was similar to that of the general population.

Cite this article as:

Anagnostis Panagiotis , Rizos V. Christos , Skoumas Ioannis , Rallidis Loukianos, Tziomalos Konstantinos , Skalidis Emmanuel, Kotsis Vasileios , Doumas Michalis, Kolovou Genovefa , Sfikas George , Bilianou Eleni, Koutagiar Iosif , Agapakis Dimitrios , Zacharis Evangelos, Antza Christina , Koumaras Charalambos , Boutari Chrysoula, Liamis George and Liberopoulos N. Evangelos*, Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH, Current Pharmaceutical Design 2021; 27 (21) . https://dx.doi.org/10.2174/1381612827666210216151645